Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Differential activation of ERKs to focal adhesions by PKC ε is required for PMA-induced adhesion and migration of human glioma cells

Abstract

Protein kinase C (PKC) is a family of serine/threonine kinases involved in the transduction of a variety of signals. There is increasing evidence to indicate that specific PKC isoforms are involved in the regulation of distinct cellular processes. In glioma cells, PKC α was found to be a critical regulator of proliferation and cell cycle progression, while PKC ε was found to regulate adhesion and migration. Herein, we report that specific PKC isoforms are able to differentially activate extracellular-signal regulated kinase (ERK) in distinct cellular locations: while PKC α induces the activation of nuclear ERK, PKC ε induces the activation of ERK at focal adhesions. Inhibition of the ERK pathway completely abolished the PKC-induced integrin-mediated adhesion and migration. Thus, we present the first evidence that PKC ε is able to activate ERK at focal adhesions to mediate glioma cell adhesion and motility, providing a molecular mechanism to explain the different biological functions of PKC α and ε in glioma cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Besson A, Yong VW . 2000 Mol. Cell. Biol. 20: 4580–4590

  • Berens ME, Giese A . 1999 Neoplasia 1: 208–219

    Article  CAS  Google Scholar 

  • El-Obeid A, Bongcam-Rudloff E, Sorby M, Ostman A, Nister M, Westermark B . 1997 Cancer Res. 57: 5598–5604

  • El-Shemerly MYM, Besser D, Nagasawa M, Nagamine Y . 1997 J. Biol. Chem. 272: 30599–30602

    Article  CAS  Google Scholar 

  • Fincham VJ, James M, Frame MC, Winder SJ . 2000 EMBO J. 19: 2911–2923

  • Friedlander DR, Zagzag D, Shiff B, Cohen H, Allen JC, Kelly PJ, Grumet M . 1996 Cancer Res. 56: 1939–1947

  • Garrington TP, Johnson GL . 1999 Curr. Opin. Cell Biol. 11: 211–218

  • Giancotti FG, Ruoslahti E . 1999 Science 285: 1028–1032

    Article  CAS  Google Scholar 

  • Gillespie GY, Soroceanu L, Manning TJ, Gladson CL, Rosenfeld SS . 1999 Cancer Res. 59: 2076–2082

  • Holland EC . 2000 Proc. Natl. Acad. Sci. USA 97: 6242–6244

  • Howe AK, Juliano RL . 1998 J. Biol. Chem. 273: 27268–27274

    Article  CAS  Google Scholar 

  • Khoshyomm S, Penar PL, Rossi J, Wells A, Abramson DL, Bhushan A . 1999 Neurosurgery 44: 568–578

    Article  CAS  Google Scholar 

  • Klemke RL, Cai S, Giannini AL, Gallagher PJ, De Lanerolle P, Cheresch DA . 1997 J. Cell Biol. 137: 481–492

  • Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P . 1999 EMBO J. 18: 2459–2471

    Article  CAS  Google Scholar 

  • Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD . 1990 Cancer Res. 50: 6039–6044

  • Miranti CK, Ohno S, Brugge JS . 1999 J. Biol. Chem. 274: 10571–10581

    Article  CAS  Google Scholar 

  • Newton AC . 1997 Curr. Opin. Cell Biol. 9: 161–167

  • Nguyen DHD, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, Weber MK, Gonias SL . 1999 J. Cell. Biol. 146: 149–164

  • Rigot V, Lehmann M, Andre F, Daemi N, Marvaldi J, Luis J . 1998 J. Cell Sci. 111: 3119–3127

  • Schaeffer HJ, Weber MJ . 1999 Mol. Cell. Biol. 19: 2435–2444

    Article  CAS  Google Scholar 

  • Schonwasser DC, Marais RM, Marshall CJ, Parker PJ . 1998 Mol. Cell. Biol. 18: 790–798

    Article  Google Scholar 

  • Short SM, Boyer JL, Juliano RL . 2000 J. Biol. Chem. 275: 12970–12977

    Article  CAS  Google Scholar 

  • Sieg DJ, Hauck CR, Schlaepfer DD . 1999 J. Cell Sci. 112: 2677–2691

  • Traub O, Monia BP, Dean NM, Berk BC . 1997 J. Biol. Chem. 272: 31251–31257

    Article  CAS  Google Scholar 

  • Tysnes OB, Laerum OD . 1993 Anticancer Res. 13: 1325–1330

  • Zhang W, Law RE, Hinton DR, Couldwell WT . 1997 Cancer Lett. 120: 31–38

Download references

Acknowledgements

We gratefully thank Tammy L Wilson for technical assistance in the adhesion assays. This work is supported by a grant from the Canadian Institutes for Health Research. A Besson is a Research Student of the National Cancer Institute of Canada supported with funds provided by the Terry Fox Run. A Davy is the recipient of an Alberta Cancer Board postdoctoral fellowship. SM Robbins is a scholar of the Alberta Heritage Foundation for Medical Research and holds a Canada Research Chair in Cancer Biology. VW Yong is a Medical Research Council of Canada Scientist and a senior scholar of the Alberta Heritage Foundation for Medical Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Wee Yong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Besson, A., Davy, A., Robbins, S. et al. Differential activation of ERKs to focal adhesions by PKC ε is required for PMA-induced adhesion and migration of human glioma cells. Oncogene 20, 7398–7407 (2001). https://doi.org/10.1038/sj.onc.1204899

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204899

Keywords

This article is cited by

Search

Quick links